
Galapagos NV GLPG
$ 28.8
-1.25%
Annual report 2025
added 04-04-2026
Galapagos NV EBITDA per Share 2011-2026 | GLPG
Annual EBITDA per Share Galapagos NV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | -2.53 | -2.75 | 6.4 K | -0.9 | -1.81 | 0.0608 | -2.41 | -1.04 | -0.284 | -0.0282 | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.4 K | -2.75 | 639 |
EBITDA per Share of other stocks in the Biotechnology industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
-188 | - | -24.86 % | $ 820 K | ||
|
Adverum Biotechnologies
ADVM
|
-6.85 | - | - | $ 86.2 M | ||
|
MorphoSys AG
MOR
|
-15.2 | - | 2.43 % | $ 254 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-1.68 | $ 3.83 | 2.56 % | $ 9.21 B | ||
|
Akouos
AKUS
|
-2.45 | - | 0.23 % | $ 488 M | ||
|
Alnylam Pharmaceuticals
ALNY
|
4.25 | $ 327.43 | -1.79 % | $ 42.9 B | ||
|
Applied Molecular Transport
AMTI
|
-3.2 | - | - | $ 10.1 M | ||
|
I-Mab
IMAB
|
0.08 | - | - | $ 866 M | ||
|
AlloVir
ALVR
|
-3.02 | - | 4.14 % | $ 49.1 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.75 | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
-2.24 | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
-0.23 | - | -13.47 % | $ 169 M | ||
|
Aligos Therapeutics
ALGS
|
-8.81 | $ 8.4 | 13.24 % | $ 83 M | ||
|
Allakos
ALLK
|
-2.19 | - | - | $ 28.6 M | ||
|
Ayala Pharmaceuticals
AYLA
|
-2.42 | - | - | $ 7.46 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.22 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-0.09 | - | -18.52 % | $ 27.3 M | ||
|
Applied Therapeutics
APLT
|
-0.77 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.92 | - | -39.0 % | $ 4.57 M | ||
|
Aravive
ARAV
|
-1.92 | - | -13.39 % | $ 1.45 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-1.05 | - | -2.5 % | $ 5.88 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
3.68 | $ 21.7 | 0.09 % | $ 1.01 B | ||
|
Burford Capital Limited
BUR
|
1.11 | $ 4.72 | -0.42 % | $ 766 M | ||
|
CymaBay Therapeutics
CBAY
|
-0.95 | - | - | $ 3.45 B | ||
|
Cabaletta Bio
CABA
|
-1.7 | $ 3.46 | 1.62 % | $ 348 M | ||
|
BioNTech SE
BNTX
|
62.6 | $ 100.8 | 1.34 % | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
-2.69 | - | - | - | ||
|
Advaxis
ADXS
|
-5.96 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
-0.08 | - | 5.93 % | $ 314 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-6.03 | $ 3.1 | -2.36 % | $ 5.1 M | ||
|
AgeX Therapeutics
AGE
|
-2.35 | - | -10.17 % | $ 12.2 K | ||
|
ContraFect Corporation
CFRX
|
-124 | - | -5.16 % | $ 5.39 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-6.7 | - | - | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
0.1 | $ 1.4 | -9.68 % | $ 360 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-0.66 | $ 4.18 | -1.3 % | $ 447 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-0.09 | $ 24.21 | -1.51 % | $ 3.08 B | ||
|
AIkido Pharma
AIKI
|
-3.89 | - | 1.93 % | $ 17.4 M | ||
|
BioDelivery Sciences International
BDSI
|
0.38 | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
-0.99 | $ 1.51 | 1.36 % | $ 402 M | ||
|
Aptose Biosciences
APTO
|
0.01 | - | -45.71 % | $ 1.2 M | ||
|
BeiGene, Ltd.
BGNE
|
0.42 | - | 0.49 % | $ 251 B | ||
|
Checkpoint Therapeutics
CKPT
|
-1.42 | - | - | $ 169 M | ||
|
Caladrius Biosciences
CLBS
|
-2.67 | - | -16.75 % | $ 25.8 M | ||
|
AVROBIO
AVRO
|
0.24 | - | 1083.1 % | $ 745 M | ||
|
Clearside Biomedical
CLSD
|
-0.4 | - | - | $ 25.3 M | ||
|
Celldex Therapeutics
CLDX
|
-4.28 | $ 33.59 | -0.82 % | $ 2.23 B | ||
|
bluebird bio
BLUE
|
-1.97 | - | - | $ 546 M | ||
|
CNS Pharmaceuticals
CNSP
|
-36 | $ 2.7 | -1.81 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
0.74 | - | - | $ 96.9 B |